Physician profile
Jonathan A Moore
NPI 1821529652
$6,221.06
in general payments reported to CMS, 2019-2025
9 companies · $5,653 in 2025
The $5,653 reported for 2025 was more than what 89% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $568 · 2025: $5,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,205 · Food and Beverage: $1,866 · Education: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,205.00 |
| Food and Beverage | $1,865.66 |
| Education | $150.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $4,954.40 | 2024-2025 | Opsynvi, Uptravi, Opsumit |
| United Therapeutics Corporation | $532.21 | 2024-2025 | Tyvaso, Tyvaso |
| Bayer Healthcare Pharmaceuticals INC. | $218.40 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $197.89 | 2024-2025 | Winrevair |
| Johnson & Johnson Health Care Systems INC. | $180.67 | 2025 | Uptravi, Opsumit |
| Ani Pharmaceuticals, INC. | $57.14 | 2025 | Purified Cortrophin Gel |
| Baxter Healthcare | $48.02 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.23 | 2025 | Ofev |
| Kestra Medical Technology Services, INC. | $14.10 | 2025 | Assure Wcd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.